Matching at the MHC class IK locus is essential for long-term engraftment of purified hematopoietic stem cells: a role for host NK cells in regulating HSC engraftment

被引:24
作者
Huang, YM
Rezzoug, F
Chilton, PM
Grimes, HL
Cramer, DE
Ildstad, ST
机构
[1] Univ Louisville, Inst Cellular Therapeut, Louisville, KY 40292 USA
[2] Univ Louisville, Dept Surg, Louisville, KY 40292 USA
关键词
D O I
10.1182/blood-2003-11-3910
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The events that regulate engraftment and long-term repopulating ability of hematopoietic stem cells (HSCs) after transplantation are not well defined. We report for the first time that major histocompatibility complex (MHC) class I K plays a critical role in HSC engraftment via interaction with recipient natural killer (NK) cells. Durable engraftment of purified HSCs requires MHC class I K matching between HSC donor and recipient. In the absence of MHC class I K matching, HSCs exhibit impaired long-term engraftment (P = .01). Dependence on MHC class I K matching is eliminated in B6 beige mice that lack NK cell function, as well as in wild-type mice depleted of NK cells, implicating a possible regulatory role of INK cells for HSC engraftment. The coadministration of CD8(+)/T-cell receptor-negative (TCR-) graft facilitating cells (FCs) matched at MHC class I K to the HISC donor overcomes the requirement for MHC class I K matching between HSCs and recipient. These data demonstrate that FCs inhibit NK cell effects on the HSCs. Notably, FCs do not suppress the cytotoxic activity of activated INK cells. Enhanced green fluorescent protein-positive (EGFP(+)) FCs persist for one month following allogeneic transplantation, making cold target inhibition an unlikely mechanism. Therefore, MHC class I may play a critical role in the initiating events that dictate HSC engraftment and/or NK-medlated rejection following allogeneic transplantation.
引用
收藏
页码:873 / 880
页数:8
相关论文
共 52 条
[1]   Hematopoietic stem cells are not direct cytotoxic targets of natural killer cells [J].
Aguila, HL ;
Weissman, IL .
BLOOD, 1996, 87 (04) :1225-1231
[2]  
Baker M B, 1995, Biol Blood Marrow Transplant, V1, P69
[3]   BONE-MARROW CELL TRANSPLANTS INVOLVING DONORS AND HOSTS WITH HAPLOTYPES DERIVED FROM SPRETUS MICE [J].
BENNETT, M ;
DORAZIO, T ;
KUMAR, V ;
STENOIEN, D ;
BLOMER, KC ;
LINDAHL, KF .
TRANSPLANTATION, 1995, 59 (10) :1452-1459
[4]   REJECTION OF CLASS-I MHC-DEFICIENT HEMATOPOIETIC-CELLS BY IRRADIATED MHC-MATCHED MICE [J].
BIX, M ;
LIAO, NS ;
ZIJLSTRA, M ;
LORING, J ;
JAENISCH, R ;
RAULET, D .
NATURE, 1991, 349 (6307) :329-331
[5]  
BOYSE EA, 1959, IMMUNOLOGY, V2, P170
[6]   DEMONSTRATION OF F1 HYBRID ANTI-PARENT IMMUNOLOGICAL REACTION [J].
CELADA, F ;
WELSHONS, WJ .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1962, 48 (03) :326-&
[7]   In vivo proliferation and cell cycle kinetics of long-term self-renewing hematopoietic stem cells [J].
Cheshier, SP ;
Morrison, SJ ;
Liao, XS ;
Weissman, IL .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1999, 96 (06) :3120-3125
[8]   Veto activity of activated bone marrow does not require perforin and Fas ligand [J].
Chrobak, P ;
Gress, RE .
CELLULAR IMMUNOLOGY, 2001, 208 (02) :80-87
[9]   Natural killer cell receptors specific for MHC class I molecules [J].
Colonna, M .
CURRENT OPINION IN IMMUNOLOGY, 1996, 8 (01) :101-107
[10]   Human cytomegalovirus, MHC class I and inhibitory signalling receptors: more questions than answers [J].
Cosman, D ;
Fanger, N ;
Borges, L .
IMMUNOLOGICAL REVIEWS, 1999, 168 :177-185